Granat - tropikalny owoc bogaty w związki bioaktywne o właściwościach prozdrowotnych

• Autorzy: Kulczynski B. , Gramza-Michalowska A.

Warianty tytułu

EN

Pomegranate - a tropical fruit rich in bioactive compounds with health-promoting properties

• Języki publikacji: PL

Abstrakty

PL

EN

Słowa kluczowe

PL

granatowiec wlasciwy; Punica granatum; owoce tropikalne; granaty [owoce]; zwiazki bioaktywne; wlasciwosci prozdrowotne; wlasciwosci przeciwutleniajace

• Wydawca: -
• Czasopismo: Nauka Przyroda Technologie. Uniwersytet Przyrodniczy w Poznaniu
• Rocznik: 2015
• Tom: 09
• Numer: 3
• Opis fizyczny: http://www.npt.up-poznan.net/pub/art_9_41.pdf

Twórcy

autor

Kulczynski B.

• Katedra Technologii Żywienia Człowieka, Uniwersytet Przyrodniczy w Poznaniu, ul.Wojska Polskiego 31/33, 60-624 Poznań

autor

Gramza-Michalowska A.

• Katedra Technologii Żywienia Człowieka, Uniwersytet Przyrodniczy w Poznaniu, ul.Wojska Polskiego 31/33, 60-624 Poznań

Bibliografia

• Akpinar-Bayizit, A., Ozcan, T., Yilmaz-Ersan, L. (2012). The therapeutic potential of pomegranate and its products for prevention of cancer. W: A. G. Georgakilas (red.), Cancer prevention - from mechanisms to translational benefits (s. 331-373). Rijeka: Intech.
• Albrecht, M., Jiang, W., Kumi-Diaka, J., Lansky, E. P., Gommersall, L. M., Patel, A., Mansel, R. E., Neeman, I., Geldof, A. A., Campbell, M. J. (2004). Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cells. J. Med. Food, 7, 3, 274-283.
• Al-Zoreky, N. S. (2009). Antimicrobial activity of pomegranate (Punica granatum L.) fruit peels. Int. J. Food Microbiol., 134, 244-248.
• Ashton, R. (2006). Growing pomegranates. W: R. Ashton, B. Baer, D. Silverstein (red.), The incredible pomegranate: plant and fruit (s. 35-38). Tempe: Third Millennium Publishing.
• Aviram, M., Dornfeld, L., Rosenblat, M., Volkova, N., Kaplan, M., Coleman, R., Hayek, T., Presser, D., Fuhrman, B. (2000). Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am. J. Clin. Nutr., 71, 1062-1076.
• Aviram, M., Rosenblat, M., Gaitini, D., Nitecki, S., Hoffman, A., Dornfeld, L., Volkova, N., Presser, D., Attias, J., Liker, H., Hayek, T. (2004). Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clin. Nutr., 23, 3, 423-433.
• Banihani, S. A., Makahleh, S. M., El-Akawi, Z., Al-Fashtaki, R. A., Khaobur, O. F., Gharibeh, M. Y., Saadah, N. A., Al-Hashimi, F. H., Al-Khasieb, N. J. (2014). Fresh pomegranate juice ameliorates insulin resistance, enhances ß-cell function, and decreases fasting serum glucose in type 2 diabetic patients. Nutr. Res., 34, 10, 862-867.
• Barzegar, M., Fadavi, A., Azizi, M. H. (2004). An investigation on the physicochemical composition of various pomegranates (Punica granatum L.) grown in Yazd. Iran. J. Food Sci. Technol., 1, 2, 9-14.
• Bhadbhade, S. J., Acharya, A. B., Rodrigues, S. V., Thakur, S. L. (2011). The antiplaque efficacy of pomegranate mouthrinse. Quintessence Int., 42, 1, 29-36.
• Bhandari, P. R. (2012). Pomegranate (Punica granatum L.). Ancient seeds for modern cure? Review of potential therapeutic applications. Int. J. Nutr. Pharmacol. Neurol. Dis., 2, 3, 171184.
• Bhowmik, D., Gopinath, H., Kumar, B. P., Duraivel, S., Aravind, G., Kumar, K. P. S. (2013). Medicinal uses of Punica granatum and its health benefits. J. Pharmacogn. Phytochem., 1, 5, 28-35.
• Bialonska, D., Kasimsetty, S. G., Schrader, K. K., Ferreira, D. (2009). The effect of pomegranate (Punica granatum L.) byproducts and ellagitannins on the growth of human gut bacteria. J. Agric. Food Chem., 57, 18, 8344-8349.
• Bialonska, D., Ramnani, P., Kasimsetty, S. G., Muntha, K. R., Gibson, G. R., Ferreira, D. (2010). The influence of pomegranate by-product and punicalagins on selected groups of human intestinal microbiota. Int. J. Food Microbiol., 140, 2-3, 175-182.
• Bishayee, A., Bhatia, D., Thoppil, R. J., Darvesh, A. S., Nevo, E., Lansky, E. P. (2011). Pomegranate-mediated chemoprevention of experimental hepatocarcinogenesis involves Nrf2-regulated antioxidant mechanisms. Carcinogenesis, 32, 6, 888-896.
• Borochov-Neori, H., Judeinstein, S., Tripler, S., Harari, M., Greenberg, A., Shomer, I., Holland, D. (2009). Seasonal and cultivar variations in antioxidant and sensory quality of pomegranate (Punica granatum L.) fruit. J. Food Comp. Anal., 22, 3, 189-195.
• Dahham, S. S., Ali, M. N., Tabassum, H., Khan, M. (2010). Studies on antibacterial and antifungal activity of pomegranate (Punica granatum L.). Am.-Eurasian J. Agric. Environ. Sci., 9, 273-281.
• Dahlawi, H., Jordan-Mahy, N., Clench, M. R., Le Maitre, C. L. (2012). Bioactive actions of pomegranate fruit extracts on leukemia cell lines in vitro hold promise for new therapeutic agents for leukemia. Nutr. Cancer, 64, 1, 100-110.
• Das, A. K., Mandal, S. C., Banerjee, S. K., Sinha, S., Saha, B. P., Pal, M. (2001). Studies on the hypoglycaemic activity of Punica granatum seed in streptozotocin induced diabetic rats. Phy-tother. Res., 15, 7, 628-629.
• El-Nemr, S. E., Ismail, I. A., Ragab, M. (2006). Chemical composition of juice and seeds of pomegranate fruit. Nahrung, 34, 7, 601-606.
• Esmaillzadeh, A., Tahbaz, F., Gaieni, I., Alavi-Majd, H., Azadbakht, L. (2006). Cholesterol-lowering effect of concentrated pomegranate juice consumption in type II diabetic patients with hyperlipidemia. Int. J. Vitam. Nutr. Res., 76, 3, 147-151.
• Fadavi, A., Barzegar, M., Azizi, M. H. (2006). Determination of fatty acids and total lipid content in oilseed of 25 pomegranates varieties grown in Iran. J. Food Comp. Anal., 19, 6-7, 676-680.
• Gil, M. I., Tomás-Barberán, F. A., Hess-Pierce, B., Holcroft, D. M., Kader, A. A. (2000). Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J. Agric. Food Chem., 48, 10, 4581-4589.
• Holland, D., Hatib, K., Bar-Ya'akov, I. (2009). Pomegranate: botany, horticulture, breeding. Hortic. Rev., 35, 127-191.
• Jasuja, N., Saxena, R., Chandra, J., Sharma, R. (2012). Pharmacological characterization and beneficial uses of Punica granatum. Asian J. Plant Sci., 11, 6, 251-267.
• Jeune, M. A., Kumi-Diaka, J., Brown, J. (2005). Anticancer activities of pomegranate extracts and genistein in human breast cancer cells. J. Med. Food, 8, 4, 469-475.
• Karczmarczuk, R. (2012). Granat - owoc mało nam znany. Wszechświat, 113, 10-12, 282-285.
• Kasimsetty, S. G., Bialonska, D., Reddy, M. K., Ma, G., Khan, S. I., Ferreira, D. (2010). Colon cancer chemopreventive activities of pomegranate ellagitannins and urolithins. J. Agric. Food Chem., 58, 4, 2180-2187.
• Kim, N. D., Mehta, R., Yu, W., Neeman, I., Livney, T., Amichay, A., Poirier, D., Nicholls, P., Kirby, A., Jiang, W., Mansel, R., Ramachandran, C., Rabi, T., Kaplan, B., Lansky, E. (2002). Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. Breast Cancer Res. Treat., 71, 3, 203-217.
• Kulczyński, B., Groszczyk, B., Cerba, A., Gramza-Michałowska, A. (2014). Owoce goi (Lycium barbarum) jako źródło związków bioaktywnych w żywności - przegląd literatury. Nauka Przyr. Technol., 8, 2, #19.
• Lansky, E. P., Jiang, W., Mo, H., Bravo, L., Froom, P., Yu, W., Harris, N. M., Neeman, I., Campbell, M. J. (2005). Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions. Invest. New Drugs, 23, 1, 11-20.
• Lansky, E. P., Newman, R. A. (2007). Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. J. Ethnopharmacol., 109, 2, 177-206.
• Larrosa, M., González-Sarrías, A., Yánez-Gascón, M. J., Selma, M. V., Azorín-Ortuno, M., Toti, S., Tomás-Barberán, F., Dolara, P., Espín, J. C. (2010). Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism. J. Nutr. Biochem., 21, 8, 717-725.
• Lee, C. J., Chen, L. G., Liang, W. L., Wanga, C. C. (2010). Anti-inflammatory effects of Punica granatum Linne in vitro and in vivo. Food Chem., 118, 315-322.
• Li, Y., Guo, C., Yang, J., Wei, J., Xu, J., Cheng, S. (2006). Evaluation of antioxidant properties of pomegranate peel extract in comparison with pomegranate pulp extract. Food Chem., 96, 2, 254-260.
• Maestre, J., Melgarejo, P., Tomás-Barberán, F. A., García-Viguera, C. (2000). New food products derived from pomegranate. W: P. Melgarejo, J. Martínez-Nicolás, J. Martínez-Tomé (red.), Production, processing and marketing of pomegranate in the Mediterranean region: advances in research and technology (s. 243-245). Zaragoza: CIHEAM.
• Makino-Wakagi, Y., Yoshimura, Y., Uzawa, Y., Zaima, N., Moriyama, T., Kawamura, Y. (2012). Ellagic acid in pomegranate suppresses resistin secretion by a novel regulatory mechanism involving the degradation of intracellular resistin protein in adipocytes. Biochem. Biophys. Res. Commun., 417, 2, 880-885.
• Malik, A., Afaq, F., Sarfaraz, S., Adhami, V. M., Syed, D. N., Mukhtar, H. (2005). Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proc. Natl. Acad. Sci. U. S. A., 102, 41, 14813-14818.
• Malik, A., Mukhtar, H. (2006). Prostate cancer prevention through pomegranate fruit. Cell Cycle, 5, 4, 371-373.
• McCarrell, E., Gould, S., Fielder, K. A., El Sankary, W., Naughton, D. (2008). Antimicrobial activities of pomegranate rind extracts: enhancement by addition of metal salts and vitamin C. BMC Complement. Altern. Med., 8, 64-70.
• McFarlin, B. K., Strohacker, K. A., Kueht, M. L. (2009). Pomegranate seed oil consumption during a period of high-fat feeding reduces weight gain and reduces type 2 diabetes risk in CD-1 mice. Br. J. Nutr., 102, 1, 54-59.
• Mehta, R., Lansky, E. P. (2004). Breast cancer chemopreventive properties of pomegranate (Punica granatum) fruit extracts in a mouse mammary organ culture. Eur. J. Cancer Prev., 13, 4, 345-348.
• Menezes, S. M., Cordeiro, L. N., Viana, G. S. (2006). Punica granatum (pomegranate) extract is active against dental plaque. J. Herb. Pharmacother., 6, 2, 79-92.
• Mertens-Talcott, S. U., Jilma-Stohlawetz, P., Rios, J., Hingorani, L., Derendorf, H. (2006). Absorption, metabolism, and antioxidant effects of pomegranate (Punica granatum L.) polyphenols after ingestion of a standardized extract in healthy human volunteers. J. Agric. Food Chem., 54, 23, 8956-8961.
• Mirmiran, P., Fazeli, M. R., Asghari, G., Shafiee, A., Azizi, F. (2010). Effect of pomegranate seed oil on hyperlipidaemic subjects: a double-blind placebo-controlled clinical trial. Br. J. Nutr., 104, 3, 402-406.
• Mohan, M., Waghulde, H., Kasture, S. (2010). Effect of pomegranate juice on Angiotensin II-induced hypertension in diabetic Wistar rats. Phytother. Res., 2, 196-203.
• Muangsan, N., Senamontee, V. (2008). Antimicrobial effects of some medicinal plant extracts against bacteria associated with black disease. Acta Hortic. (Chiang Mai), 786, 73-76.
• Naz, S., Siddiqi, R., Ahmad, S., Rasool, S. A., Sayeed, S. A. (2007). Antibacterial activity directed isolation of compounds from Punica granatum. J. Food Sci., 72, 9, 341-345.
• de Nigris, F., Balestrieri, M. L., Williams-Ignarro, S., D'Armiento, F. P., Fiorito, C., Ignarro, L. J., Napoli, C. (2007). The influence of pomegranate fruit extract in comparison to regular pomegranate juice and seed oil on nitric oxide and arterial function in obese Zucker rats. Nitric Oxide, 17, 1, 50-54.
• Opara, L. U., Al-Ani, M. R., Al-Shuaibi, Y. S. (2009). Physico-chemical properties, vitamin C content, and antimicrobial properties of pomegranate fruit (Punica granatum L.). Food Bio-process Technol., 2, 3, 315-321.
• Ozgul-Yucel, S. (2005). Determination of conjugated linolenic acid content of selected oil seeds grown in Turkey. J. Am. Oil Chem. Soc., 82, 12, 893-897.
• Parmar, H. S., Kar, A. (2007). Antidiabetic potential of Citrus sinensis and Punica granatum peel extracts in alloxan treated male mice. Biofactors, 31, 1, 17-24.
• Parmar, H. S., Kar, A. (2008). Medicinal values of fruit peels from Citrus sinensis, Punica granatum, and Musa paradisiaca with respect to alterations in tissue lipid peroxidation and serum concentration of glucose, insulin, and thyroid hormones. J. Med. Food, 11, 2, 376-381.
• Pasha, C., Sayeed, S. A., Ali, S., Khan, Z. (2009). Antisalmonella activity of selected medicinal plants. Turk. J. Biol., 33, 59-64.
• POMASA - Pomegranate Association of South Africa. (2013). Pomegranate production guidelines. Paarl. Pozyskano z: www.sapomegranate.co.za/wp-content/uploads/2013/11/POMASA--Technical-Production-Manual.pdf [dostęp: 21 -12-2014].
• Prashanth, D. J., Asha, M. K., Amit, A. (2001). Antibacterial activity of Punica granatum. Fitoter-apia, 72, 171-173.
• Rock, W., Rosenblat, M., Miller-Lotan, R., Levy, A. P., Elias, M., Aviram, M. (2008). Consumption of wonderful variety pomegranate juice and extract by diabetic patients increases paraoxonase 1 association with high-density lipoprotein and stimulates its catalytic activities. J. Agric. Food Chem., 56, 18, 8704-8713.
• Sadeghi, N., Jannat, B., Oveisi, M. R., Hajimahmoodi, M., Photovat, M. (2009). Antioxidant activity of Iranian pomegranate (Punica granatum L.) seed extracts. J. Agric. Sci. Technol., 11, 633-638.
• Salgado, L., Melgarejo, P., Meseguer, I., Sánchez, M. (2009). Antimicrobial activity of crude extracts from pomegranate (Punica granatum L.). Acta Hortic. (Adana), 818, 257-264.
• Singh, R. P., Murthy, K. N. C., Jayaprakasha, G. K. (2002). Studies on the antioxidant activity of pomegranate peel and seed extracts using in vitro models. J. Agric. Food Chem., 50, 1, 81-86.
• Singh, D., Singh, R. K. (2004). Processed products of pomegranate. Nat. Prod. Radian., 3, 2, 66-68.
• Sreekumar, S., Sithul, H., Muraleedharan, P., Azeez, J. M., Sreeharshan, S. (2014). Pomegranate fruit as a rich source of biologically active compounds. Biomed Res. Int., 2014, 1-12.
• Stowe, C. B. (2011). The effects of pomegranate juice consumption on blood pressure and cardiovascular health. Complement. Ther. Clin. Pract., 17, 2, 113-115.
• Sudheesh, S., Vijayalakshmi, N. R. (2005). Flavonoids from Punica granatum - potential antiper-oxidative agents. Fitoterapia, 76, 181-186.
• Szulińska, M., Pupek-Musialik, D. (2006). Rezystyna - rola w rozwoju insulinooporności - fakty i kontrowersje. Nadciśn Tętn., 10, 4, 301-306.
• Tezcan, F., Gültekin-Özgüven, M., Diken, T., Ozęelik, B., Erim, B. (2009). Antioxidant activity and total phenolic, organic acid and sugar content in commercial pomegranate juices. Food Chem., 115, 3, 873-877.
• Toi, M., Bando, H., Ramachandran, C., Melnick, S. J., Imai, A., Fife, R. S., Carr, R. E., Oikawa, T., Lansky, E. P. (2003). Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo. Angiogenesis, 6, 2, 121-128.
• Tzulker, R., Glazer, I., Bar-Ilan, I., Holland, D., Aviram, M., Amir, R. (2007). Antioxidant activity, polyphenol content and related compounds in different fruit juices and homogenates prepared from 29 different pomegranate accessions. J. Agric. Food Chem., 55, 23, 9559-9570.
• U.S. Department of Agriculture, Agricultural Research Service. (2014). USDA National Nutrient Database for Standard Reference, Release 27. Nutrient Data Laboratory Home Page. Pozyskano z: http://www.ars.usda.gov/ba/bhnrc/ndl [dostęp: 20-12-2014].
• Viuda-Martos, M., Fernández-López, J., Pérez-Álvarez, J. A. (2010). Pomegranate and its many functional components as related to human health: a review. Compr. Rev. Food Sci. Food Saf., 9, 635-654.
• Wang, R., Ding, Y., Liu, R., Xiang, L., Du, L. (2010). Pomegranate: constituents, bioactivities and pharmacokinetics. Fruit Veg. Cereal Sci. Biotechnol., 4, 2, 77-87.
• Zielaskowska, J., Olszewska-Słonina, D. (2006). The polymorphism of paraoxonase and its effects in physiological and pathological processes. Adv. Clin. Exp. Med., 15, 6, 1073-1078.

Identyfikatory

DOI

10.17306/J.NPT.2015.3.41